Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | GAL |
| Upstream (Parents) |
|---|
| (<<) CASP4 → GAL |
| (<<) CCNB2 → GAL |
| (<<) CD79A → GAL |
| (<<) CHAC1 → GAL |
| (<<) CNIH4 → GAL |
| (<<) CXCL3 → GAL |
| (<<) DDX21 → GAL |
| (<<) DUSP2 → GAL |
| (<<) EMG1 → GAL |
| (<<) HDAC2 → GAL |
| (<<) ITGAE → GAL |
| (<<) JAK1 → GAL |
| (<<) LAMB2 → GAL |
| (<<) PRDX6 → GAL |
| (<<) RHOF → GAL |
| (<<) RPS16 → GAL |
| (<<) ST3GAL1 → GAL |
| (<<) STC2 → GAL |
| (<<) TARS → GAL |
| (<<) UAP1 → GAL |
| Downstream (Children) |
|---|
| GAL → CRCT1 (>>) |
| GAL → EIF4EBP1 (>>) |
| GAL → KHDRBS3 (>>) |
| GAL → MN1 (>>) |
| GAL → RPA4 (>>) |
| GAL → TNXB (>>) |
